Thomas Krannich

Thomas Krannich


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2020 in Science
Verified
Journal Article
Closed access
FRFrancisca M. Real
Francisca M. Real
SHStefan A. Haas
Stefan A. Haas
PFPaolo Franchini
Paolo Franchini
PXPeiwen Xiong
Peiwen Xiong
OSOleg Simakov
Oleg Simakov
DLDarío G. Lupiáñez
Darío G. Lupiáñez
Intersexuality in female moles: Female moles are intersexual and develop masculinizing ovotestes, a distinctive trait among mammals. Real et al. investigated the origin of this trait by sequencing the Iberian mole genome and applying comparative strategies that integrate transcriptomic, epigenetic, and chromatin interaction data. They identified mole-specific genomic rearrangements that alter the three-dimensional regulatory landscape of the androgen-converting gene CYP17A1 and the pro-testicular factor gene FGF9 , both of which show distinct expression patterns in mole gonads. The use of transgenic mice confirms the capability of these factors to increase circulating testosterone levels and to induce gonadal masculinization. This study highlights how integrative approaches can reveal the phenotypic impact of genomic variation. Science , this issue p. 208

2 November 2021 in Bioinformatics
Verified
Journal Article
Open access
PDF file
TKThomas Krannich
Thomas Krannich
WWW Timothy J White
W Timothy J White
SNSebastian Niehus
Sebastian Niehus
GHGuillaume Holley
Guillaume Holley
BHBjarni V Halldórsson
Bjarni V Halldórsson
BKBirte Kehr
Birte Kehr
With the increasing throughput of sequencing technologies, structural variant (SV) detection has become possible across tens of thousands of genomes. Non-reference sequence (NRS) variants have drawn less attention compared with other types of SVs due to the computational complexity of detecting them. When using short-read data, the detection of NRS variants inevitably involves a de novo assembly which requires high-quality sequence data at high coverage. Previous studies have demonstrated how sequence data of multiple genomes can be combined for the reliable detection of NRS variants. However, the algorithms proposed in these studies have limited scalability to larger sets of genomes. We introduce PopIns2, a tool to discover and characterize NRS variants in many genomes, which scales to considerably larger numbers of genomes than its predecessor PopIns. In this article, we briefly outline the PopIns2 workflow and highlight our novel algorithmic contributions. We developed an entirely new approach for merging contig assemblies of unaligned reads from many genomes into a single set of NRS using a colored de Bruijn graph. Our tests on simulated data indicate that the new merging algorithm ranks among the best approaches in terms of quality and reliability and that PopIns2 shows the best precision for a growing number of genomes processed. Results on the Polaris Diversity Cohort and a set of 1000 Icelandic human genomes demonstrate unmatched scalability for the application on population-scale datasets. The source code of PopIns2 is available from https://github.com/kehrlab/PopIns2. Supplementary data are available at Bioinformatics online.

31 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
JFJonas Fuchs
Jonas Fuchs
JKJohanna Kleine
Johanna Kleine
MSMathias Schemmerer
Mathias Schemmerer
JKJulian Kreibich
Julian Kreibich
WMWolfgang Maier
Wolfgang Maier
MPMarcus Panning
Marcus Panning
Time- and cost-saving surveillance of viral pathogens is achieved by tiled sequencing in which a viral genome is amplified in overlapping PCR amplicons and qPCR. However, designing pan-specific primers for viral pathogens with high genomic variability represents a significant challenge. Here, we present a bioinformatics command-line tool, called varVAMP (variable virus amplicons), which addresses this issue. It relies on multiple sequence alignments of highly variable virus sequences and enables degenerate primer design for qPCR or tiled amplicon whole genome sequencing. We demonstrate the utility of varVAMP by designing and evaluating novel pan-specific primer schemes suitable for sequencing the genomes of SARS-CoV-2, Hepatitis E virus, rat Hepatitis E virus, Hepatitis A virus, Borna-disease-virus-1, and Poliovirus using clinical samples. Importantly, we also designed primers on the same input data using the software packages PrimalScheme and Olivar and showed that varVAMP minimizes primer mismatches most efficiently. Finally, we established highly sensitive and specific Poliovirus qPCR assays that could potentially simplify current Poliovirus surveillance. varVAMP is open-source and available through PyPI, UseGalaxy, Bioconda, and https://github.com/jonas-fuchs/varVAMP.

9 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JFJonas Fuchs
Jonas Fuchs
JKJohanna Kleine
Johanna Kleine
MSMathias Schemmerer
Mathias Schemmerer
JKJulian Kreibich
Julian Kreibich
WMWolfgang Maier
Wolfgang Maier
MPMarcus Panning
Marcus Panning
Time- and cost-saving surveillance of viral pathogens is achieved by tiled sequencing in which a viral genome is amplified in overlapping PCR amplicons and qPCR. However, designing pan-specific primers for viral pathogens that have high genomic variability represents a major challenge. Here, we present a bioinformatics command-line tool, called varVAMP ( var iable v irus amp licons). It relies on multiple sequence alignments of highly variable virus sequences and enables automatic pan-specific primer design for qPCR or tiled amplicon whole genome sequencing. The varVAMP software guarantees pan-specificity by two means: it designs primers in regions with minimal variability and introduces degenerate nucleotides into primer sequences to compensate for common sequence variations. We demonstrate varVAMP’s utility by designing and evaluating novel pan-specific primer schemes suitable for sequencing the genomes of SARS-CoV-2, Hepatitis E virus, rat Hepatitis E virus, Hepatitis A virus, Borna-disease-virus-1, and Poliovirus. Moreover, we established highly sensitive and specific Poliovirus qPCR assays that could potentially simplify current Poliovirus surveillance. Importantly, wet-lab and bioinformatic techniques established for SARS-CoV-2 tiled amplicon sequencing were readily transferable to these new primer schemes and will allow sequencing laboratories to extend their established methodology to other human pathogens.

8 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
LDLuca Denti
Luca Denti
PBPaola Bonizzoni
Paola Bonizzoni
BBBroňa Brejová
Broňa Brejová
RCRayan Chikhi
Rayan Chikhi
TKThomas Krannich
Thomas Krannich
FHFereydoun Hormozdiari
Fereydoun Hormozdiari
Pangenomes are becoming increasingly popular data structures for genomics analyses due to their ability to compactly represent the genetic diversity within populations. Constructing a pangenome graph, however, is still a time-consuming and expensive process. A promising approach for pangenome construction consists of progressively augmenting a pangenome graph with additional high-quality assemblies. Currently, there is no method for augmenting a pangenome graph with unassembled reads from newly sequenced samples without first aligning the reads to a reference genome and performing variant calling and genotyping on the new individuals. In this work, we present the first assembly-free and mapping-free approach for augmenting an existing pangenome graph using unassembled long reads from an individual not already present in the pangenome. Our approach consists of finding sample specific sequences in reads using efficient indexes, clustering reads corresponding to the same novel variant(s), and then building a consensus sequence to be added to the pangenome graph for each variant separately. Using simulated reads based on Human Pangenome Reference Consortium (HPRC) assemblies, we demonstrate the effectiveness of the proposed approach for progressively augmenting the pangenome with long reads, without the need for de novo assembly or predicting genetic variants of the new sample. The software is freely available at https://github.com/ldenti/palss .

1 September 2025 in bioRxiv
Verified
Preprint
Open access
LDLuca Denti
Luca Denti
TKThomas Krannich
Thomas Krannich
Tomas VinarTomas Vinar
Tomas Vinar
RCRayan Chikhi
Rayan Chikhi
PBPaola Bonizzoni
Paola Bonizzoni
FHFereydoun Hormozdiari
Fereydoun Hormozdiari
Structural variants (SVs) are medium and large-scale genomic alterations that shape phenotypic diversity and disease risk. Numerous methods have been proposed for discovering SVs, however their benchmarking has been inconsistent across studies, often resulting in contradictory findings. One of the main sources of conflicting evaluation re-sults is the lack of consistency in the SV callsets used as ground truth, ranging from curated callsets released by consortia to more recent approaches that construct callsets from high-quality telomere-to-telomere de novo haplotype assemblies. The discrepancies between benchmarks are further compounded by the choice of the reference genome ( GRCh37 , GRCh38 , and T2T-CHM13 ), where using T2T-CHM13 reveals a different deletion/insertion profile, indicating reduced reference bias. We evaluated the performance of several state-of-the-art SV discovery methods from long-read whole-genome sequencing data and observed substantial variation in their performance and rankings, depending on the choice of ground truth, reference genome, and genomic regions used for evaluation. Counter-intuitively, the more complete reference genome T2T-CHM13 does not inherently solve the problem of SV benchmarking; instead it reveals the limitations of each detection method in complex genomic regions. The substantial variation in detection accuracy across different genomic regions calls for additional caution in downstream analyses and in drawing conclusions based on predicted SVs. These findings underscore the complexity of evaluating SV detection methods and highlight the need for careful consideration and, ideally, field-standard best practices when reporting performance metrics.